November 8, 2013
Military Contractor Fraud
The federal False Claims Act is a statute concerned with eliminating misspending and misrepresentations with regard to private use of public money. While many of our stories involve healthcare fraud claims under the FCA, a recent case stemming out of George Washington University, located in Washington D.C., highlights the need […]
November 7, 2013
False Claims Act Legal News
Yesterday, we introduced a series detailing proposed changes to the False Claims Act. These ideas are purported by the Institute for Legal Reform to be a fairer, more evenhanded approach to the allegedly disproportionate distribution of justice under the current FCA. For instance, the ILR believes in a multiplier system […]
November 5, 2013
False Claims Act Legal News
As we have so often reported in the past, the False Claims Act and its state-level counterparts are some of the most successful pieces of legislation in American history. Beginning in the Civil War era, the FCA has proven integral in recover billions of U.S. tax dollars from the hands […]
November 4, 2013
Omnicare
Berger Montague, one of the nation’s preeminent whistleblower law firms, recently announced its $120 million victory against pharmacy services company Omnicare, Inc. The settlement enters the record books as the highest-ever False Claims Act settlement wherein the U.S. government did not intervene. We reported last week about Omnicare’s extensive experience […]
November 1, 2013
False Claims Act Legal News
In yesterday’s post, we discussed the details of the case we are working on against Omnicare, Inc. and various other pharmacy service companies. We provided an in-depth look into Medicare Part A and D benefits and how Omnicare was profiting from kickbacks offered to nursing homes desperate to provide cost-effective […]
October 28, 2013
False Claims Act Legal News
At Berger and Montague, we pride ourselves on effective, thorough representation of individual whistleblowers eager to expose fraudulent misconduct against the government. As you may have gathered from previous posts, the U.S. government does not always intervene in every whistleblower case. However, we remain dedicated to our clients and continue […]
October 24, 2013
False Claims Act Legal News
The Taxpayers Against Fraud Education Fund is a non-profit organization dedicated to increasing awareness of fraud committed against the government, such as healthcare, Medicaid and Medicare fraud. In its new study, it has concluded that for every $1 invested in fighting fraud, lawsuits arising under the FCA return nearly $20. […]
October 23, 2013
False Claims Act Legal News
In a press release issued by the Federal Bureau of Investigation, it was announced that K-Mart has agreed to pay the United States and 32 participating states $2.55 million to settle allegations of false prescription claims. Under the False Claims Act, which has been ratified or closely mimicked by several […]
October 22, 2013
Healthcare Fraud
Any individual with original information about fraudulent Medicaid or Medicare claims may come forward as a whistleblower under the federal False Claims Act (“FCA”). Under the FCA, it is considered against the law for a doctor to offer or implant a medical device that is known to be faulty and […]
October 21, 2013
SEC Fraud
The Dodd-Frank Act, enacted in 2010, is dedicated to avoiding the financial misconduct which gave rise to America’s financial crisis of 2008. Under this Act, there is a provision focused on whistleblowers with original knowledge of fraud in the commodities trading industry. What is commodities trading? Commodities trading is better […]
October 21, 2013
False Claims Act Information
It is not uncommon for a whistleblower case to result in a settlement or order valued in the millions of dollars. In this article, we focus on cases with ten-figure settlements, including some approaching the billion-dollar mark. Interestingly, the majority of companies that were affected by these expensive settlements arising […]
October 18, 2013
Healthcare Fraud
The False Claims Act bars, among other things, unlawful kickbacks to physicians pertaining to any patient interaction to be subsequently billed to Medicare or Medicaid. The FCA also prohibits drug manufacturers from marketing or selling products in ways other than those approved by the FDA. Any deviation from the approved […]